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Mutations in the TIGR Gene in Familial Primary
Open-Angle Glaucoma in Japan
To the Editor:
As described in an editorial by Raymond (1997), glau-
coma is characterized by progressive excavation of the
optic disk, with both loss of retinal nerve fiber and visual
field defects. This disease is one of the most common
causes of bilateral blindness, and it is estimated that by
the year 2000 ∼66.8 million people worldwide will be
affected by it (Quigley 1996). Recently, the glaucoma
geneGLC1A was shown to be identical to the trabecular
meshwork–inducible glucocorticoid response (TIGR)
gene (TIGR) (Stone et al. 1997). The TIGR gene was
cloned by Polansky and colleagues (Nguyen et al. 1993;
Polansky et al. 1997) and, also, was called “myocilin”
(gene MYOC) when it was cloned by Kubota et al.
(1997). Three different mutations in the gene were
shown to be responsible for the development of primary
open-angle glaucoma (POAG), the most common form
of glaucoma (Stone et al. 1997). The prevalence of these
mutations was reported to be 4.4% in familial POAG
patients and 2.9% in unselected POAG patients (Stone
et al. 1997). We investigated whether Japanese patients
with familial POAG carry identical or other mutants on
the same gene. As a result, two new mutations in the
TIGR gene were found. The prevalence of mutations in
the TIGR gene in Japanese patients with familial POAG
was also investigated.
Peripheral blood samples were collected, with in-
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Figure 1 Chromatograms of nucleotide sequences from patients with mutations (A and B) and from a normal control (C). The double
peak of cytosine (blue line) and thymine (red line) (A, red arrow) represents a heterozygous mutation in the codon corresponding to the 370th
amino acid residue of the TIGR protein (Pro370Leu). The double peak of guanine (black line) and adenine (green line) (B, green arrow) represents
a heterozygous mutation at the codon of 367th amino acid residue (Gly367Arg).
Figure 2 Pedigree of patients with the Pro370Leumutation. The
proband is indicated by an arrow.
formed consent, from 52 POAG patients of 50 pedigrees
with a family history. The patients were diagnosed with
POAG, by ocular and systemic examinations. The family
history was obtained by direct interview with the pa-
tients. Subjects having at least one relative with POAG
within the third degree of relationship were defined as
belonging to a pedigree having familial POAG. They all
had an elevated intraocular pressure (x22 mmHg),
open-angle (Shaffer grade III or IV), visual-field loss
characteristic of glaucoma, and glaucomatous optic-disk
damage. Blood samples from five normal healthy vol-
unteer were also obtained, as controls, with informed
consent. Genomic DNA was purified from these blood
samples by use of a QIAGEN QIAamp Blood Kit. A
DNA fragment encoding a portion of the TIGR protein
(amino acid residues 317–476, exon 3; GenBank acces-
sion number U85257-AF001620) was amplified, with
samples of the purified genomic DNA used as templates,
by PCR. The nucleotide sequences of primers used
are 5′-ATACTGCCTAGGCCACTGGA (sense strand)
and 5′-CATGCTGCTGTACTTATAGCGG (antisense
strand). A 150-ng template was mixed with 10 ml of
10 # buffer, 8 ml of the deoxynucleotides mixture, 10
pmol of each primer, and 0.5 ml of Taq polymerase
(AmpliTaq Gold; Perkin Elmer), to produce a 100-ml
PCR mixture. The nucleotide sequences of both strands
of the PCR products were directly determined with the
terminator cycle–sequencing method, by use of fluores-
cent dideoxynucleotides and an automatic DNA se-
quencer (Applied Biosystems). Mutation was recognized
by the approximately equal peak intensity of two fluo-
rescent dyes at the mutation site. When a mutation was
detected, the whole procedure of PCR and sequencing
was repeated, and the existence of the mutation was
confirmed.
Of the 52 patients from the 50 pedigrees, 2 patients
of one family (a father and a daughter [who was the
proband]) carried a heterozygous CrT mutation at the
second nucleotide position in the codon corresponding
to the 370th amino acid residue of the TIGR protein,
resulting in an amino acid change from proline to leucine
(Pro370Leu) (figs. 1A and 2). The father was diagnosed
with POAG at age 26 years old, the daughter at age 16
years. One other patient, from a different pedigree, had
a heterozygous GrA mutation at the first nucleotide
position in the codon corresponding to the 367th amino
acid residue, resulting in an amino acid change from
glycine to arginine (Gly367Arg) (fig. 1B). She was di-
agnosed with POAG at age 45 years. Both mutations
were different from those reported elsewhere (Stone et
al. 1997). In the pedigree with the Pro370Leu mutation,
the mother and a sister of the proband were examined
and proved to have neither symptoms of glaucoma nor
mutations in the TIGR gene portion examined (fig. 2).
Therefore, the mutation was inherited in an autosomal
dominant manner. The patient with the Gly367Arg mu-
tation had a family history, in that at least her two aunts
and five cousins had POAG; but we could not obtain
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blood samples from her relatives. The prevalence of the
mutations in the TIGR gene was 4.0% (2/50 families),
which was comparable to that reported in a previous
study (Stone et al. 1997).
The present study has revealed that mutations in the
TIGR gene are also responsible for familial POAG in
Japan. The mutations in the third exon of the TIGR
gene were found to be associated with ∼4% of Japanese
familial POAG patients. The prevalence of themutations
in the gene was comparable in Japanese patients and in
the population previously studied. The mutated sites,
however, were different from those reported in the pre-
vious study, and no common mutations were found.
Therefore, the distribution of the mutated sites in the
TIGR gene in Japanese POAG may be different from
those in other races. Known mutated sites in the TIGR-
gene disease alleles are at the 364th, 367th, 368th,
370th, and 437th amino acid residues. The apparent
focus of the reported mutations—around the 367th
amino acid residue—indicates that the amino acid
change around this position may play a critical role in
the pathogenesis of POAG. The TIGR-protein product
is overexpressed with glucocorticoid stimulation and is
thought to contribute to steroid-responsive intraocular-
pressure increase, by the obstruction of aqueous outflow
(Nguyen et al. 1993; Polansky et al. 1997). Further in-
vestigations of the TIGR gene will reveal more infor-
mation about the pathogenesis of POAG.
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Childhood Cancer and Neural Tube Defects
To the Editor:
In the March 1997 issue of the Journal, Narod et al.
(1997) concluded that cases of spina bifida and of ab-
normalities of the eye, ribs, and spine were more com-
mon in children with cancer than among population-
based controls. In an invited editorial in the same issue,
Friedman (1997) called for additional work to define
more clearly the associations between congenital anom-
alies and cancer and to differentiate those associations
that are spurious from those that are biologically
important.
I wish to comment on the reported association be-
tween spina bifida and cancer, which was based on com-
parison of the relative frequency of specific types of
anomalies in children with cancer who were diagnosed
in Great Britain during the period 1971–86 with the
corresponding relative frequency in liveborn children
born in British Columbia during the period 1969–88. In
addition to the differences in methods of ascertainment
discussed by Narod et al. (1997), this comparison ap-
pears to be inappropriate, since the prevalence of neural
tube defects at birth was markedly higher in the British
Isles than in Canada, from the 1950s to the early 1980s
(Little and Elwood 1992). This difference was apparent
despite the decline in the prevalence of these defects at
birth in the British Isles since the early 1970s. In Canada,
there has been a persistent east-west gradient, with the
prevalence at birth declining from the east toward the
west.
In the study by Narod et al. (1997), when the 275
cases with an established genetic cause were excluded,
the prevalence of neural tube defects at birth among
children diagnosed with childhood cancer was 1.2 per
1,000 births. As noted by Narod et al., anencephalus is
associated with a high rate of infant mortality, and most
children with neural tube defects are likely to have had
